108 related articles for article (PubMed ID: 12007802)
1. Strain-dependent effects of environmental signals on the production of extracellular phospholipase by Cryptococcus neoformans.
Wright LC; Chen SC; Wilson CF; Simpanya MF; Blackstock R; Cox GM; Murphy JW; Sorrell TC
FEMS Microbiol Lett; 2002 Apr; 209(2):175-81. PubMed ID: 12007802
[TBL] [Abstract][Full Text] [Related]
2. Phospholipase activity in Cryptococcus neoformans: a new virulence factor?
Chen SC; Muller M; Zhou JZ; Wright LC; Sorrell TC
J Infect Dis; 1997 Feb; 175(2):414-20. PubMed ID: 9203663
[TBL] [Abstract][Full Text] [Related]
3. Identification of extracellular phospholipase B, lysophospholipase, and acyltransferase produced by Cryptococcus neoformans.
Chen SC; Wright LC; Santangelo RT; Muller M; Moran VR; Kuchel PW; Sorrell TC
Infect Immun; 1997 Feb; 65(2):405-11. PubMed ID: 9009289
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic characterization of clinical and environmental Cryptococcus neoformans strains isolated in Italy.
Pini G; Faggi E; Campisi E
Rev Iberoam Micol; 2017; 34(2):77-82. PubMed ID: 28215482
[TBL] [Abstract][Full Text] [Related]
5. Comparison of phospholipase production in Cryptococcus neoformans isolates from AIDS patients and bird droppings.
Vidotto V; Leone R; Sinicco A; Ito-kuwa S; Criseo G
Mycopathologia; 1998; 142(2):71-6. PubMed ID: 9926419
[TBL] [Abstract][Full Text] [Related]
6. Cryptococcal phospholipases: a novel lysophospholipase discovered in the pathogenic fungus Cryptococcus gattii.
Wright LC; Payne J; Santangelo RT; Simpanya MF; Chen SC; Widmer F; Sorrell TC
Biochem J; 2004 Dec; 384(Pt 2):377-84. PubMed ID: 15320865
[TBL] [Abstract][Full Text] [Related]
7. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans.
Cox GM; McDade HC; Chen SC; Tucker SC; Gottfredsson M; Wright LC; Sorrell TC; Leidich SD; Casadevall A; Ghannoum MA; Perfect JR
Mol Microbiol; 2001 Jan; 39(1):166-75. PubMed ID: 11123698
[TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of secretory phospholipase B, lysophospholipase and lysophospholipase/transacylase from a virulent strain of the pathogenic fungus Cryptococcus neoformans.
Chen SC; Wright LC; Golding JC; Sorrell TC
Biochem J; 2000 Apr; 347(Pt 2):431-9. PubMed ID: 10749672
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and functional characterisation of secreted phospholipase activities from Cryptococcus neoformans in their naturally occurring state.
Santangelo RT; Nouri-Sorkhabi MH; Sorrell TC; Cagney M; Chen SCA; Kuchel PW; Wright LC
J Med Microbiol; 1999 Aug; 48(8):731-740. PubMed ID: 10450996
[TBL] [Abstract][Full Text] [Related]
10. Biochemical comparison of the Cu,Zn superoxide dismutases of Cryptococcus neoformans var. neoformans and Cryptococcus neoformans var. gattii.
Hamilton AJ; Holdom MD
Infect Immun; 1997 Feb; 65(2):488-94. PubMed ID: 9009302
[TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal activities of inhibitors of phospholipases from the fungal pathogen Cryptococcus neoformans.
Ganendren R; Widmer F; Singhal V; Wilson C; Sorrell T; Wright L
Antimicrob Agents Chemother; 2004 May; 48(5):1561-9. PubMed ID: 15105106
[TBL] [Abstract][Full Text] [Related]
12. [Characterization of Cryptococcus neoformans strains isolated from patients with acquired immunodeficiency syndrome (AIDS)].
Garza-Garza D; Buendía-Uribe JL; Martínez-Cruz E; Argüero-Licea B
Rev Latinoam Microbiol; 1995; 37(3):273-9. PubMed ID: 8850346
[TBL] [Abstract][Full Text] [Related]
13. Extracellular DNase activity of Cryptococcus neoformans and Cryptococcus gattii.
Sánchez M; Colom F
Rev Iberoam Micol; 2010 Mar; 27(1):10-3. PubMed ID: 20167522
[TBL] [Abstract][Full Text] [Related]
14. Role and mechanism of phosphatidylinositol-specific phospholipase C in survival and virulence of Cryptococcus neoformans.
Chayakulkeeree M; Sorrell TC; Siafakas AR; Wilson CF; Pantarat N; Gerik KJ; Boadle R; Djordjevic JT
Mol Microbiol; 2008 Aug; 69(4):809-26. PubMed ID: 18532984
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic activity of a clinical isolate of Cryptococcus neoformans.
Brueske CH
J Clin Microbiol; 1986 Mar; 23(3):631-3. PubMed ID: 3514663
[TBL] [Abstract][Full Text] [Related]
16. Phospholipase activity in Cryptococcus neoformans.
Vidotto V; Sinicco A; Di Fraia D; Cardaropoli S; Aoki S; Ito-Kuwa S
Mycopathologia; 1996-1997; 136(3):119-23. PubMed ID: 9276940
[TBL] [Abstract][Full Text] [Related]
17. [Phenotype characterization of environmental Cryptococcus neoformans isolates].
Huérfano S; Cepero MC; Castañeda E
Biomedica; 2003 Sep; 23(3):328-40. PubMed ID: 14582336
[TBL] [Abstract][Full Text] [Related]
18. [In vitro determination of virulence factors activity associated with several Cryptococcus neoformans clinical isolates].
Sánchez A; Escandón P; Castañeda E
Rev Iberoam Micol; 2008 Sep; 25(3):145-9. PubMed ID: 18785782
[TBL] [Abstract][Full Text] [Related]
19. Measuring Urease and Phospholipase Secretion in Cryptococcus neoformans.
Hoffman HJ; McClelland EE
Methods Mol Biol; 2024; 2775():269-275. PubMed ID: 38758324
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterisation of the phospholipase B gene of Cryptococcus neoformans var. gattii.
Latouche GN; Sorrell TC; Meyer W
FEMS Yeast Res; 2002 Dec; 2(4):551-61. PubMed ID: 12702271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
